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Abstract
Objectives: To explore the impact of implementation of Community-Acquired 
Pneumonia (CAP) quality care bundle.
Setting: Eight acute hospitals in the North East of England and North Cumbria.
Participants: ICD-10 coded CAP aged >18 were identified. A total of 16 201 CAP 
patients were discharged 2016/2017 (15 707; 2015/2016 and 10 733; 2014/2015).
Outcome measures: Secondary User Service (SUS) data were collected monthly 
from April 2014 to 2017. Data were pseudonymised and data flows governed by Data 
Sharing Agreements. CAP measures were based on British Thoracic Society guid-
ance and agreed following clinician consultation. CAP admissions and individual 
organisational compliance with and impact of, CAP quality bundle measures was 
explored.
Results: Average length of stay (LOS) was 10.4 days (median 6) 25% >13 days. 
Crude in-hospital mortality rate was 17.6%, significantly lower (95% CI) than 19.1% 
in 2015/2016 and 19.3% in 2014/2015. Emergency readmissions within 28 days were 
19.7% (19.2%; 2015/2016, 17.9%; 2014/2015). A total of 39.5% of patients received 
all appropriate care measures. Compliance has improved over time, although not for 
all hospitals. Most quality measures have higher mortality for those passing measures 
compared to those failing (P < .05 95% CI). Giving oxygen, had a significantly higher 
emergency readmission rate, 3.3% higher (95% CI 1.1% to 5.5%). Appropriate antibiot-
ics and recording CURB-65 scores reduced the emergency readmission rates (−2.7% 
(95% CI −4.5% to −0.8%) −2.6% (95% CI −3.8% to −1.4%), respectively, (P = ns)).
Conclusion: CAP accounts for significant bed days, mortality and readmissions. 
Although mortality was lower, LOS and readmission rates were not, despite im-
provements in compliance after implementation of the care bundle. Care bundle use 
remained sub-optimal.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2020 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd
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K E Y W O R D S
community-acquired pneumonia, ICD-10 code, standardised hospital mortality
1 |  INTRODUCTION
Community-acquired pneumonia (CAP) is defined as pneu-
monia acquired outside hospital or health-care facilities. CAP 
tends to affect older people and is associated with significant 
morbidity and mortality. Current estimates describe pneumonia 
as affecting 29 000 people per annum in the United Kingdom 
with 5%-15% of those hospitalised dying within 30 days of 
admission. Pneumonia is responsible for more hospital admis-
sions and bed days than any other respiratory condition.1,2
The supposition is that CAP care bundles improve the 
outcomes from pneumonia if widely and systematically im-
plemented.3,4 In this study, we explore the implementation 
of CAP quality measures as a mechanism for assessing use 
and impact of care bundle implementation in acute hospital 
settings across the whole of the United Kingdom North East 
and North Cumbria (NENC) geographical region.
The report focuses on process and outcomes, comparing 
the outcomes for patients over time, against the regional out-
comes and based on the type of treatment received, specifi-
cally, whether patients passed, failed or were excluded from 
the pneumonia measures.
2 |  METHODOLOGY
2.1 | Setting
This study was conducted across ICD-10 coded CAP patients 
(Appendix Table A1)
over the age of 18 in eight acute hospitals in the North 
East of England using a unified database. Secondary User 
Service (SUS) data were collected by Clarity Informatics 
Limited from each hospital monthly from April 2014 to 
2017. Data were pseudonymised at source and all data flows 
were governed by Data Sharing Agreements with each trust 
to ensure appropriate Information Governance.
2.2 | Community-acquired pneumonia 
quality measures
The seven CAP measures are based on the widely accepted 
British Thoracic Society guidance3,4 with details of operational 
definitions of the measures agreed across all hospitals follow-
ing consultation with clinicians and nurses from the hospitals 
via a series of workshops and meetings are as follows;
• CAP-1: Chest X-ray or CT scan of thorax within 4hrs of 
hospital arrival
• CAP-2: Oxygen assessed within 1hr of hospital arrival
• CAP-3: Oxygen given within 1hr of hospital arrival
• CAP-4: Initial antibiotic received within 4hrs of hospital 
arrival
• CAP-5: Appropriate initial antibiotic regimen received
• CAP-6: Defines whether a clinical prediction tool (CURB-
65 or CRB-65 Score) is recorded
• CAP-7: Critical care advice given if CURB-65 score = 4 or 
5 or CRB-65 score = 3 or 4
Clinically appropriate exclusions were applied to the pa-
tient population, for example, if a patient was designated as 
needing palliative care. The measures were agreed and col-
lected initially with three trusts in 2014 with inclusion of a 
further five trusts in 2015.The care bundle itself was widely 
accepted as reflecting existing clinical practice, albeit, not 
consistently delivered quickly. The only measure which in-
volved a change in practice (rather than just increasing the 
timeliness of existing care) was the routine calculation of a 
clinical risk prediction tool such as CURB-65 or CRB-65 
Score. All the hospitals involved in the project participated 
in a series of bespoke workshops aimed at educating teams 
about the bundle and the evidence for its benefits. In addi-
tion, teams developed a sticker for the notes that acted as an 
aid memoire so that all elements of the bundle were com-
pleted. These efforts at improvement were shared through the 
workshops.
2.3 | Outcome measures
We examined three main outcome measures, average length 
of stay (LOS), crude mortality rate and rate of emergency 
readmissions within 28 days of discharge.
Length of stay for pneumonia patients is described in days 
and presented as both mean and median values.
Crude in-hospital mortality rate was determined as the 
number of patients coded with a discharge method (patient 
died) or a discharge destination (patient died) divided by the 
total number of patient spells.5
An emergency readmission rate was defined as the num-
ber of patients who are readmitted as an emergency, within 
28 days of discharge, divided by the total number of live 
discharges.
2.4 | Process
Initially we considered the overall CAP admissions and 
compliance with the CAP quality bundle measures as a 
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whole. We then went onto consider individual organisa-
tions and their compliance with the CAP quality bundle 
measures and then, the impact of the measures and the rela-
tionship with outcomes. We defined two scores. The appro-
priate care score (ACS) was the number of those patients 
who received all relevant elements of care defined in the 
bundle and composite process score (CPS) the number of 
those patients who receive any element of the care defined 
in the bundle.
2.5 | Patient and public involvement
Patients and members from regional patient support groups 
were involved in the education workshops. Patients and the 
public were not involved in the design of the study, its imple-
mentation or analysis.
3 |  RESULTS
3.1 | CAP prevalence rates
We identified 16 201 pneumonia patients discharged during 
April-March 2016/2017 for NENC Hospital trusts, this com-
pares to 15 707 and 10 733 patients for the same period for 
2015/2016 and 2014/2015, respectively.
The average age for pneumonia patients at NENC Hospital 
Trusts in 2016/2017 was 73.9 years. Median age was 78 
years. Half of all patients were between 67 and 85 years old 
at discharge with 25% of patients being 85 years or older. The 
age profile has remained relatively constant over time. The 
key parameters for pneumonia patients at NENC Hospital 
Trusts for the 3 years from April 2014 to March 2017 are 
shown in Figure 1.
The age profile varies across trusts, Newcastle Hospitals 
having the youngest pneumonia population with an average 
age of 71.1 years whilst South Tyneside Hospital have the 
oldest, average age 75.5 years.
3.2 | Outcome measures
Outcomes over time are shown in Table 1.
3.2.1 | Length of stay
The average LOS for pneumonia patients at NENC Hospital 
Trusts in 2016/2017 was 10.4 days. The median LOS was 6 
days. Half of all patients stayed in hospital for between 3 and 
13 days, 25% of patients were in hospital for 13 days or longer. 
The LOS profile for pneumonia patients at NENC Hospital 
Trusts has remained consistent for the most recent 2 years of 
the programme and slightly higher than in 2014/2015.
3.2.2 | Mortality
In April-March 2016/2017, the crude mortality rate for 
Pneumonia patients at NENC trusts was 17.6%, this is sig-
nificantly lower (95% CI) than the 19.1%in April-March 
2015/2016 and 19.3% in April-March 2014/2015.
3.2.3 | Emergency readmissions
In April-March 2016/2017, the rate of emergency readmis-
sions within 28 days for Pneumonia patients at NENC trusts 
was 19.7%, compared to 19.2% in April-March 2015/2016 
and 17.9% in April-March 2014/2015 (Table 1).
3.3 | Quality measures data
For NENC Hospital trusts, from April 2014 to March 2017 
compliance with the bundle of quality measures has varied 
between measures, with lowest compliance for recording of 
a clinical risk prediction tool (CURB-65 score) at 47.5%, to 
highest compliance for oxygen assessment within 1 hour of 
F I G U R E  1  Summary of key figures 
for NENC Hospital trusts, from April 2014 
to March 2017
4 |   MORROW et al.
hospital arrival at 85.5%. Only 39.5% of patients received all 
appropriate care measures, that is, they received all measures 
that they were eligible to receive. Overall, bundle measure 
compliance improved over time, although not for all trusts.
A patient is deemed to have ‘passed’ a measure if they are 
eligible for the measure activity and the activity was given 
within the specified time scales. Figure 2A shows the pass 
rates for individual NENC Hospital Trusts, for each measure, 
from April 2014 to March 2017 discharges with Figure 2B 
showing this over t time.
3.4 | Relationship between compliance with 
CAP quality measures and outcomes
3.4.1 | Length of stay
Length of stay is a difficult outcome to monitor. Average LOS 
is heavily influenced by just one or two long stay patients, 
median LOS is more consistent but rarely identifies differ-
ences. We found no statistical difference for LOS across time 
or with adherence to the CAP measure bundle.
3.4.2 | Mortality
Figure 3 below shows crude mortality rates plotted on a fun-
nel plot for NENC Hospital Trusts, for eligible patients for 
each pneumonia measure, by pass status, for April 2014 to 
March 2017 discharges.
The data presented visualises the impact of pass or fail for 
each measure. Above the mean line represents increased num-
bers of deaths associated with a measure, below the line rep-
resents decreased numbers of deaths. Ideally, passing a measure 
(green circle) would always be found below the mean and fail-
ing a measure (red diamond) would be associated with a figure 
above the mean. In addition, the data labels are coloured green 
when the crude mortality rate for patients who pass a measure 
is lower than for those who fail and where one of those patient 
groups is significantly (99.8%) different than the mean for all 
eligible patients. Conversely, the data labels are coloured red 
when the crude mortality rate for patients who pass is higher 
than those who fail and one of those patient groups is signifi-
cantly (99.8%) different than the mean for all eligible patients.
Table 2 below shows the above data in tabular form, 
showing the difference in the crude mortality rate between 
eligible patients who pass a measure compared to those who 
fail, 95% confidence intervals for the differences are included 
along with Fisher’s exact P value from a 2-proportion test.
Overall, most measures have higher mortality rates for eli-
gible patients who pass measures compared to those who fail 
and these differences are statistically significant (95% CI). 














































































































































































































































   | 5MORROW et al.
score recorded. Mortality is 17.5% for those who fail this 
measure, mortality is 14.1% for those who pass, therefore, the 
difference is 3.4% lower (95% CI −4.7% to −2.2%). Eligible 
patients who receive appropriate antibiotics also show a re-
duced crude mortality rate but not significantly so.
3.4.3 | Emergency readmissions within 
28 days
In order to visualise, by pass status, for April 2014 to March 
2017 discharges emergency readmission rates were plotted 
on a funnel plot for North East trusts, for eligible patients for 
each pneumonia measure.
For emergency readmissions, oxygen given, has a sig-
nificantly higher emergency readmission rate for patients 
who pass the measure compared to those who fail that is, is 
visualised with the funnel plot as an outlier, 3.3% higher (95% 
CI 1.1% to 5.5%). Two measures, appropriate antibiotics and 
CURB-65 score recorded show significantly reduced emer-
gency readmission rates, these are −2.7% (95% CI −4.5% to 
−0.8%) and −2.6% (95% CI −3.8% to −1.4%), respectively. 
For all other measures, the differences in readmission rates 
are not statistically significant.
4 |  DISCUSSION
CAP is common and in our study prevalence rose during 
the period. CAP is also seasonal (with higher rates in win-
ter) and with considerable variation between years depend-
ent up on the epidemiology of microbes circulating in the 
population. In this study, identification was based on clini-
cal coding in administrative data from a number of different 
F I G U R E  2  A, Pass rates by Measure for NENC Hospital Trusts, from April 2014 to Mar 2017 discharges. B, Measure Pass rates over time for 
NENC Hospital Trusts. The sparkline bars demonstrate the trend of performance for each measure. The dark green denotes the best performance by 
quarter and the red bar provides the data from the worst performing quarter
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F I G U R E  3  Funnel plots by pass status for North East trusts, from April 2014 to March 2017. The data presented visualises the impact of 
pass or fail for each measure. Above the mean line represents increased numbers of deaths associated with a measure, below the line represents 
decreased numbers of deaths. Ideally, passing a measure (green circle) would always be found below the mean and failing a measure (red diamond) 
would be associated with a figure above the mean. In addition, the data labels are coloured green when the crude mortality rate for patients who 
pass a measure is lower than for those who fail and where one of those patient groups is significantly (99.8%) different than the mean for all eligible 
patients. In contrast, the data labels are coloured red when the crude mortality rate for patients who pass is higher than those who fail and one of 
those patient groups is significantly (99.8%) different than the mean for all eligible patients. A, Crude mortality rate; B, Emergency Readmission 
Rates
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NHS organisations from across a large geographical area in 
the North of England. Whilst this process is stable variation 
in identification, documentation and coding are all subject 
to some variation. CAP is the diagnosis responsible for the 
highest volume of deaths in the hospital mortality Summary 
Hospital-level Mortality Indicator (SHMI), it accounts for 
very significant numbers of bed days, in our study had a 17% 
readmission rate and is one of the most significant sources 
of cost and unplanned activity for any NHS hospital. It is, 
therefore, important that service improvement strategies aim 
to target this condition to reduce LOS, readmission and mor-
tality rates.
Although mortality was lower in the final year of the proj-
ect, LOS and readmission rates were not despite improve-
ments in compliance with the care bundle. Use of the care 
bundle remained suboptimal despite 3 years of effort and 
whilst some of this may be related to accuracy of documen-
tation and auditing it is likely that the complexity of hospital 
care systems make it difficult for staff to consistently identify 
and treat patients with CAP in a timely manner.
A major aim of the programme was to demonstrate that pa-
tients have improved outcomes (reduced LOS, mortality and 
emergency readmissions within 28 days) when they receive 
appropriate CAP quality care measures. We have looked for 
variations in outcomes between eligible patients who pass a 
measure and those who fail.
Overall, most measures have higher mortality rates for eli-
gible patients who pass measures compared to those who fail 
and these differences are statistically significant (95% CI).
This seems counterintuitive, but could suggest that those 
with more severe CAP might be recognised and the care bun-
dle complied with whilst less severe CAP is less recognised.
The exceptions are patients who have clinical prediction 
risk score (CURB-65 or CRB-65) recorded. For patients who 
pass this measure the crude mortality rate is 3.4% (95% CI 
−4.7% to −2.2%) lower than for patients who fail the measure 
suggesting that the use of such tools may raise awareness and 
led to better outcomes for patients.6,7 Eligible patients who 
receive appropriate antibiotics also show a reduced crude 
mortality rate but not significantly so. There are a range of 
possible reasons for why crude mortality rates are higher for 
patients who pass a measure than for those who fail, the most 
likely is that we are unable to provide an accurate standard-
isation for severity of pneumonia, complexity, co-morbidity 
and case mix analysis.
Readmissions show a different picture, oxygen given, 
has a significantly higher emergency readmission rate for 
patients who pass the measure compared to those who fail, 
3.3% higher (95% CI 1.1% to 5.5%). This may be in keeping 
with previous studies that suggest that treatments that include 
oxygen therapy in CAP may affect respiratory drive and as a 
consequence possibly increase the risk of further events.8,9 
Two measures, appropriate antibiotics and CURB-65 score 
recorded show reduced emergency readmission rates, these 
are −2.7% (95% CI −4.5% to −0.8%) and −2.6% (95% CI 
−3.8% to −1.4%), respectively, which has been noted in pre-
vious studies.10 For all other measures, the differences in re-
admission rates are not statistically significant.
For average LOS, no statistical significance was found.
It is important to acknowledge any potential limitations 
to our study. Our data exploring the outcomes is not risk-ad-
justed and it is not possible to account for random variation 
or secular trends in case mix between years at this stage. The 
volume and severity of pneumonia changes from year to year 
as the prevalence and virulence of causative micro-organ-
isms circulating in the population changes. It is not possible 
to measure the variation in case-mix in this study. Data using 
a risk-adjusted measure of mortality based on the Summary 
Hospital-level Mortality Indicator (SHMI) estimates of pre-
dicted mortality would overcome these difficulties.
In conclusion, our study has shown that CAP is common 
and accounts for significant numbers of bed days, mortality 
and readmissions. Although mortality was lower in the final 
year of the project, LOS and readmission rates were not, de-
spite improvements in compliance with the care bundle. Care 
bundle use remained sub-optimal, which may be related to 
accuracy of documentation. It is likely that the complexity of 
hospital care systems make it difficult for staff to consistently 
identify and treat patients with CAP in a timely manner.
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APPENDIX 
T A B L E  A 1  Clinical ICD-10 Coding used to define community-acquired pneumonia (CAP)
Code Definition
CAP
J13 Pneumonia due to Streptococcus pneumonia
J14 Pneumonia due to Haemophilus influenza
J150 Pneumonia due to Klebsiella pneumonia
J151 Pneumonia due to Pseudomonas
J152 Pneumonia due to staphylococcus
J153 Pneumonia due to streptococcus, group B
J154 Pneumonia due to other streptococci
J155 Pneumonia due to Escherichia coli
J156 Pneumonia due to other aerobic Gram-negative bacteria
J157 Pneumonia due to Mycoplasma pneumonia
J158 Other bacterial pneumonia
J159 Bacterial pneumonia, unspecified
J160 Chlamydial pneumonia
J168 Pneumonia due to other specified infectious organisms
J180 Bronchopneumonia, unspecified
J181 Lobar pneumonia, unspecified
J182 Hypostatic pneumonia, unspecified
J188 Other pneumonia, organism unspecified
J189 Pneumonia, unspecified
Septicaemia
A400 Septicaemia due to streptococcus, group A
A401 Septicaemia due to streptococcus, group B
A402 Septicaemia due to streptococcus, group D
A403 Septicaemia due to Streptococcus pneumonia
A408 Other streptococcal septicaemia
A409 Streptococcal septicaemia, unspecified
A410 Septicaemia due to Staphylococcus aureus
A411 Septicaemia due to other specified staphylococcus
A412 Septicaemia due to unspecified staphylococcus
A413 Septicaemia due to Haemophilus influenza
A414 Septicaemia due to anaerobes
A415 Septicaemia due to other Gram-negative organisms
A418 Other specified septicaemia
A419 Septicaemia, unspecified
Respiratory failure
J960 Acute respiratory failure
J962 Acute and chronic respiratory failure
Cystic fibrosis
E84.0 Cystic fibrosis with pulmonary manifestations
E84.1 Cystic fibrosis with intestinal manifestations
E84.8 Cystic fibrosis with other manifestations (including combined manifestations)
E84.9 Cystic fibrosis, unspecified
